N4BP2L2 Antibody (OTI1C8) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72866B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG2A Clone # OTI1C8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length recombinant protein of human N4BP2L2 (NP_055702) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for N4BP2L2 Antibody (OTI1C8) [Biotin]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: N4BP2L2
Alternate Names
CG005FLJ41089, CG016, FLJ36195, NEDD4 binding protein 2-like 2, NEDD4-binding protein 2-like 2, PFAAP5FLJ43077, Phosphonoformate immuno-associated protein 5,92M18.3,92M18.3 (novel protein), protein from BCRA2 region
Gene Symbol
N4BP2L2
Additional N4BP2L2 Products
Product Documents for N4BP2L2 Antibody (OTI1C8) [Biotin]
Product Specific Notices for N4BP2L2 Antibody (OTI1C8) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...